Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
Yang Y, He Y, Fan Z, Chen X, Liu Y, Zhang C, Jiang H, Wang X, Wang X, Xie F, Wang S, Luo B, Kang H, Wang T, Jiang Z, Yuan P, Xu B, Xu L, Liu Y, Li J, Xie Y, Wang T, Ouyang T.
Yang Y, et al.
NPJ Breast Cancer. 2023 Jul 24;9(1):62. doi: 10.1038/s41523-023-00567-6.
NPJ Breast Cancer. 2023.
PMID: 37488099
Free PMC article.
No abstract available.